Donor ID | Age | Sex | Primary path Dx | Additional path Dx | A-beta (Thal) (1–5) | Braak stage (1–6) | Neuritic plaque (CERAD, Biel) | Diffuse plaque (CERAD, Biel) |
---|---|---|---|---|---|---|---|---|
Case1 | 62 | M | AD | – | 5 | 6 | Frequent | Frequent |
Case2 | 70 | M | AD, DLB | CVD | 5 | 6 | Frequent | Frequent |
Case3 | 72 | M | AD, LBD | – | 5 | 5 | Moderate | Frequent |
Case4 | 70 | F | AD | CHR CB Degen | 5 | 6 | Frequent | Frequent |
Case5 | 82 | M | AD, LBD | CVD, SDH | 5 | 5 | Frequent | Frequent |
Control1 | 71 | M | N/A | N/A | N/A | N/A | N/A | N/A |
Control2 | 72 | F | N/A | N/A | N/A | N/A | N/A | N/A |
Control3 | 73 | M | N/A | N/A | N/A | N/A | N/A | N/A |
Control4 | 71 | M | N/A | N/A | N/A | N/A | N/A | N/A |